Suppr超能文献

COVID-19 疫苗指南数量众多,但许多指南在方法实践的报告方面缺乏透明度。

COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices.

机构信息

Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Lanzhou University Institute of Health Data Science, Lanzhou, China.

School of Public Health, Lanzhou University, Lanzhou, China.

出版信息

J Clin Epidemiol. 2022 Apr;144:163-172. doi: 10.1016/j.jclinepi.2021.12.015. Epub 2021 Dec 14.

Abstract

OBJECTIVE

To describe the current status of COVID-19 vaccine guidelines.

STUDY DESIGN AND SETTING

We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively.

RESULTS

A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%).

CONCLUSION

A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed.

摘要

目的

描述 COVID-19 疫苗指南的现状。

研究设计和设置

我们搜索了数据库、Google 和指南平台,以检索 2020 年 1 月 1 日至 2021 年 7 月 8 日期间发布的 COVID-19 疫苗指南。我们两人一组识别合格的指南,并提取有关方法学、资金和利益冲突是否评估/报告等数据。结果以描述性方式呈现。

结果

共纳入 106 项 COVID-19 疫苗指南。2021 年上半年,平均每月发布 15 项指南。50 项(47.2%)指南针对具有特定医疗条件的人群的疫苗接种,18 项(17.0%)指南关注疫苗接种后的不良反应。只有 28 项(26.4%)指南报告了他们使用的方法学。有 4 项(3.8%)指南评估了证据质量和推荐强度;42 项(39.6%)和 65 项(61.3%)指南分别报告了资金来源和利益冲突。大多数指南以英文发表(n=92,86.8%)。

结论

最近几个月发布了大量关于 COVID-19 疫苗的指南,但大多数指南缺乏对方法学、资金和利益冲突的明确和透明报告。需要对这些指南进行严格的方法学和报告质量评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2066/8669940/6f7dc9c77750/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验